FoxO proteins: cunning concepts and considerations for the cardiovascular system.
about
Novel nervous and multi-system regenerative therapeutic strategies for diabetes mellitus with mTORErythropoietin and diabetes mellitusStem cell guidance through the mechanistic target of rapamycinFoxO Transcription Factors and Regenerative Pathways in Diabetes MellitusNew Insights for Oxidative Stress and Diabetes MellitusFoxO3a governs early microglial proliferation and employs mitochondrial depolarization with caspase 3, 8, and 9 cleavage during oxidant induced apoptosis.Oxidative stress: Biomarkers and novel therapeutic pathways.New strategies for Alzheimer's disease and cognitive impairment.Diabetes mellitus: channeling care through cellular discoveryThe FOX transcription factors regulate vascular pathology, diabetes and TregsThe "O" class: crafting clinical care with FoxO transcription factors.Novel avenues of drug discovery and biomarkers for diabetes mellitus.EPO relies upon novel signaling of Wnt1 that requires Akt1, FoxO3a, GSK-3β, and β-catenin to foster vascular integrity during experimental diabetes.Erythropoietin employs cell longevity pathways of SIRT1 to foster endothelial vascular integrity during oxidant stress.Signaling via PI3K/FOXO1A pathway modulates formation and survival of human embryonic stem cell-derived endothelial cells.Translating cell survival and cell longevity into treatment strategies with SIRT1Targeting cardiovascular disease with novel SIRT1 pathways.Tongxinluo Protects against Hypertensive Kidney Injury in Spontaneously-Hypertensive Rats by Inhibiting Oxidative Stress and Activating Forkhead Box O1 Signaling.Cardiovascular disease and mTOR signalingMammalian target of rapamycin signaling in diabetic cardiovascular diseaseRegeneration in the nervous system with erythropoietinWISP1 neuroprotection requires FoxO3a post-translational modulation with autoregulatory control of SIRT1Forkhead transcription factors: new considerations for alzheimer's disease and dementia.The forkhead transcription factor FOXO3a controls microglial inflammatory activation and eventual apoptotic injury through caspase 3The vitamin nicotinamide: translating nutrition into clinical care.A fork in the path: Developing therapeutic inroads with FoxO proteins.Association study to evaluate FoxO1 and FoxO3 gene in CHD in Han Chinese.Programming apoptosis and autophagy with novel approaches for diabetes mellitus.Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders.Harnessing the Power of SIRT1 and Non-coding RNAs in Vascular Disease.NOX4 mediates activation of FoxO3a and matrix metalloproteinase-2 expression by urotensin-IIAssociation Analysis of FOXO3 Longevity Variants With Blood Pressure and Essential Hypertension.mTOR: Driving apoptosis and autophagy for neurocardiac complications of diabetes mellitus.Forkhead Transcription Factors: Formulating a FOXO Target for Cognitive Loss.Novel Treatment Strategies for the Nervous System: Circadian Clock Genes, Non-coding RNAs, and Forkhead Transcription Factors.FoxO proteins in the nervous system.The role of reciprocal activation of cAbl and Mst1 in the oxidative death of cultured astrocytes.
P2860
Q26749047-CD7C9D65-1E2C-4D0A-8343-022A726FACAFQ26777878-E1031ADE-337B-425F-B123-E0F74209B9FDQ26795544-FF06779E-2B63-44BB-A489-7790871C5C89Q26800615-5455A90F-1376-4B33-B85D-830081A5BB71Q28080679-A8CC191E-843F-44D3-8956-1AA6BA909512Q33604706-947EF5E4-AEAD-4282-BDB3-6FF1432CB908Q33682262-1149C4C6-7774-42C5-89FB-0F2A4AA915BCQ33717008-DAAC7210-B5B0-495D-A67F-AC468A57A791Q33749358-BDA2E5C6-8CE1-4AF2-81BE-937120FB4FB9Q33763033-AB3886F0-DEB0-4159-B82A-02B9F886277BQ33824809-76BEA65E-DC32-4295-90D3-DCA5DD2E773FQ34552287-2B65D343-6DF5-43D1-8B4C-379102EE8869Q34887803-937CAC9B-26D7-457F-98E8-ABDB7DAF0A63Q35146283-D625C8E6-3265-45C3-8BD4-0982E256A26BQ35200248-AE2B4290-2685-4532-B825-BD3679C23BBEQ35660308-172D9968-CBE5-4C02-B644-EF1055E4C278Q35661632-ADCEC435-90A8-4B95-9F81-4A4B73160214Q35870169-6BAD8181-FF73-49DA-B798-FE15FCA554D9Q36062316-A4108C65-B42F-499A-81EF-A044DBEED550Q36100715-762F8A8F-C6E3-4C1C-8751-189DC69A66CDQ36247651-F93AD032-CE75-4ECC-9A2E-DA885AD1CE99Q36597808-96C3B402-C0CA-452F-AFD4-B8F2AE18CE7DQ37064987-F0DB3CF9-8F18-45F2-8A7F-6CA244924F96Q37156425-54EDA225-4F4E-49EA-9AA2-26251B55A715Q37374047-23641E7C-5239-42C2-B7A8-702B8F2CF9B3Q37390262-EA081A10-BA30-4BEF-943B-C19890392C96Q37525331-D0740064-3A2B-407E-BAEF-21474DA985A0Q38367977-FF371463-5A45-405B-A06C-F3343542B62BQ38607849-546C3AC6-1722-4ED3-8165-B5BF2C7C8E39Q38789540-2DF94DB4-6316-4828-A5E7-499F1E2AEE2EQ39124068-927774B9-FB34-4601-A89C-D112592016DEQ40421290-822DA810-C9F4-4A29-9AC9-B1C0414D698AQ42031136-7CB9795C-6834-46B2-BEA6-F60D08FF1D89Q45305554-9505D4E5-D785-42E6-B7C6-EA4DDB33EB8FQ51761339-4D608839-233F-4167-AE66-782F8FF3B918Q53622309-00CE6A83-3987-4F58-8B9A-59AFB404176FQ54381962-108F643E-4FA3-41D8-B8E2-BDEB336FA50B
P2860
FoxO proteins: cunning concepts and considerations for the cardiovascular system.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
FoxO proteins: cunning concepts and considerations for the cardiovascular system.
@en
FoxO proteins: cunning concepts and considerations for the cardiovascular system.
@nl
type
label
FoxO proteins: cunning concepts and considerations for the cardiovascular system.
@en
FoxO proteins: cunning concepts and considerations for the cardiovascular system.
@nl
prefLabel
FoxO proteins: cunning concepts and considerations for the cardiovascular system.
@en
FoxO proteins: cunning concepts and considerations for the cardiovascular system.
@nl
P2093
P2860
P356
P1433
P1476
FoxO proteins: cunning concepts and considerations for the cardiovascular system.
@en
P2093
Jinling Hou
Kenneth Maiese
Yan Chen Shang
Zhao Zhong Chong
P2860
P304
P356
10.1042/CS20080113
P407
P577
2009-02-01T00:00:00Z